Partner, Monograph Capital
Originally trained as a pharmacologist, Tim is a biotech investor and company builder.
He was part of the founding team at Autolus, Gyroscope, Casma Therapeutics, MiroBio via his investing roles at Syncona and Third Rock Ventures and Oxford Sciences Innovation
He is now a London Partner of the transatlantic venture firm Monograph Capital where he leads investments in Ascend, Aviado and Maxion.
Tim spent time in Boston where he first witnessed the benefits of an LGBTQ network for the biotech industry and he has worked to catalyse a similarly supportive environment in the UK by establishing OUTbio UK.